抽吸取栓与导管定向溶栓治疗中危肺栓塞的比较效果
本研究回顾性分析2017-2022年多医院医疗系统中332例中危肺栓塞患者,比较导管定向溶栓(CDT,152例)与抽吸取栓(ST,180例)。经逆概率治疗加权后,ST组主要复合终点发生率显著高于CDT组(wOR 4.4),主要由补救干预需求增加驱动;ST组右心应变缓解率更高(wOR 3.46)。
要点
- 经IPTW调整后,ST组主要复合终点发生率显著高于CDT组(wOR 4.4,95%CI 1.27-15.3)。
- ST组补救干预需求显著高于CDT组(wOR 3.7,95%CI 1.04-13.4)。
- ST组右心应变缓解率显著高于CDT组(wOR 3.46,95%CI 1.32-9.11)。
核心结论
- 与大出血或ICU住院时间相比,CDT组无统计学显著降低。
- CDT应继续作为中危肺栓塞介入治疗的重要组成部分。
研究设计与样本
- 回顾性综述多医院医疗系统2017-2022年间中危肺栓塞的介入治疗(CDT或ST)。
- 共纳入332例患者,其中CDT组152例,ST组180例。
- 中危肺栓塞定义为影像学(超声心动图和/或计算机断层扫描血管造影)显示右心应变或生物标志物(肌钙蛋白或B型利钠肽)升高。
- 排除高风险肺栓塞(收缩压<90 mmHg)或接受全身溶栓治疗的患者。
- 采用逆概率治疗加权(IPTW)调整组间基线不平衡,生成加权比值比(wOR)。
主要发现
- IPTW后分析显示,7天死亡率、30天死亡率、大出血或颅内出血无差异。
关键数值与推荐
- 主要复合终点包括7天全因死亡、颅内出血、大出血、临床恶化和/或需要补救治疗。
临床怎么用
- 中危肺栓塞介入治疗中,CDT应继续作为介入治疗的重要组成部分。
- ST与主要复合终点和补救干预需求增加相关,选择ST时需权衡。
- ST与右心应变缓解率更高相关,可能在适当选择的中危肺栓塞患者中有益。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Catheter-directed thrombolysis (CDT) has been shown to rapidly reverse hemodynamic and echocardiographic abnormalities seen in intermediate-risk pulmonary embolism (IRPE). Suction thrombectomy (ST) devices have emerged as alternative treatment modalities demonstrating immediate results, obviating the need for thrombolytics. Comparative data between the two methods are sparse. METHODS: We retrospectively reviewed interventions for IRPE (CDT or ST) at a multihospital health care system (2017-2022). IRPE was defined by evidence of right heart strain (RHS) on imaging (echocardiogram and/or computed tomography angiography) or elevated biomarkers (troponin or B-natriuretic peptide). Patients with high-risk PE (systolic blood pressure <90 mmHg) or those who received systemic thrombolytics were excluded. The primary endpoint was a composite of 7-day all-cause mortality, intracranial bleeding, major bleeding, clinical deterioration, and/or need for bailout therapy. Secondary outcomes included the primary endpoint individual components, intensive care unit length of stay, 30-day mortality, and resolution of RHS at 3 months. Inverse probability of treatment weighting (IPTW) was used to adjust for baseline imbalances between groups, generating weighted odds ratios (wORs). RESULTS: A total of 332 patients were included, with 152 patients with CDT and 180 with ST. IPTW successfully balanced baseline differences between groups (Table I). On univariable analysis, the primary outcome did not differ between groups (CDT 6.6% vs ST 12.8%; P = .06), but ST was associated with increased 30-day mortality (CDT 1.3% vs ST 5.5%; P = .039) and the need for bailout intervention (CDT 4.6% vs ST 11.1%; P = .031). Major bleeding occurred in 3.3% CDT vs 2.2% ST (P = .551). There were no intracranial bleeds. Post-IPTW analysis showed a significantly higher rate of the primary outcome in the ST group (wOR, 4.4; 95% confidence interval [CI], 1.27-15.3; P = .02). There were no differences in 7-day mortality, 30-day mortality, major bleeding, or intracranial bleeding. The need for bailout intervention was significantly higher in the ST group (wOR, 3.7; 95% CI, 1.04-13.4; P = .044). The use of ST was significantly associated with resolution of RHS (wOR, 3.46; 95% CI, 1.32-9.11; P = .012). CONCLUSIONS: ST is associated with significantly increased odds of the primary outcome in patients with IRPE when compared with CDT after IPTW. These results were mainly driven by the bailout intervention rate. There was no statistically significant reduction in major bleeding or intensive care unit length of stay compared with CDT. RHS resolved more frequently in patients after ST, suggesting there may be benefit to rapid thrombus removal in appropriately selected patients with IPRE despite the increased need for bailout therapy. CDT should remain an integral part of the interventional armamentarium in IRPE.
引用
- Alie-Cusson FS, Jarosinski M, Reitz KM, et al. Comparative effectiveness of suction thrombectomy versus catheter-directed thrombolysis in intermediate-risk pulmonary embolism. J Vasc Surg. 2025. PMID: 40543679. doi:10.1016/j.jvs.2025.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。